Tissue tracking imaging as a new modality for identifying the origin of idiopathic ventricular arrhythmias - 21/08/11
Doi : 10.1016/j.amjcard.2004.10.047
Hiroshi Tada, MD a, ⁎ 
, Hiroyuki Toide, RMS a, Shigeto Naito, MD a, Sachiko Ito, MD a, Kenji Kurosaki, MD a, Yasuyuki Kobayashi, RMS a, Kohei Miyaji, MD a, Minoru Yamada, MD a, Shigeru Oshima, MD a, Akihiko Nogami, MD b, Koichi Taniguchi, MD a
, Hiroyuki Toide, RMS a, Shigeto Naito, MD a, Sachiko Ito, MD a, Kenji Kurosaki, MD a, Yasuyuki Kobayashi, RMS a, Kohei Miyaji, MD a, Minoru Yamada, MD a, Shigeru Oshima, MD a, Akihiko Nogami, MD b, Koichi Taniguchi, MD a a Division of Cardiology, Gunma Prefectural Cardiovascular Center, Maebashi, Gunma, Japan
b Division of Cardiology, Yokohama Rosai Hospital, Yokohama, Kanagawa, Japan
*Dr. Tada's address is: Division of Cardiology, Gunma Prefectural Cardiovascular Center, 3-12 Kameizumi, Maebashi, Gunma 371-0004, Japan
Résumé |
Tissue tracking imaging was performed in 33 patients with idiopathic ventricular arrhythmias before radiofrequency catheter ablation. The site of the arrhythmia origin, defined as the site where the earliest color-coded signal appeared on the myocardium at the onset of the arrhythmia, corresponded to the site of origin as determined on fluoroscopy during activation mapping in all patients. Catheter ablation at that site abolished the arrhythmia in 29 patients (88%).
Le texte complet de cet article est disponible en PDF.© 2005
Excerpta Medica Inc. Tous droits réservés.
Vol 95 - N° 5
P. 660-664 - mars 2005 Retour au numéro
Article précédent
- Safety of perioperative statin use in high-risk patients undergoing major vascular surgery
- Olaf Schouten, Miklos D. Kertai, Jeroen J. Bax, Anai E.S. Durazzo, Elena Biagini, Eric Boersma, Virginie H. van Waning, Thomas W. Lameris, Marc R.H.M. van Sambeek, Don Poldermans
- Time to resumption of driving after implantation of an automatic defibrillator (from the Dual chamber and VVI Implantable Defibrillator [DAVID] trial)
- Chris Baessler, Sheryl Murphy, Laura Gebhardt, Trevor Tso, Kenneth Ellenbogen, Robert Leman, DAVID Investigators *
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?